Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yueze Liu

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Cancer Letters|August 9, 2025
Organoids in the research of pancreatic neoplasms: cultivation, applications, and limitationsChangwei Du, Yueze Liu, Xiaoyue Lu, et al.
Biomarker Research|January 25, 2024
Ribosome profiling: a powerful tool in oncological researchDan Su, Chen Ding, Jiangdong Qiu, et al.
Free Radical Biology & Medicine|May 19, 2024
E3 ubiquitin ligase RBCK1 confers ferroptosis resistance in pancreatic cancer by facilitating MFN2 degradationDan Su, Chen Ding, Ruobing Wang, et al.
Cancer Management and Research|June 26, 2024
Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Treated Pancreatic CancerJianchun Xiao, Fangyu Zhao, Wenhao Luo, et al.
Journal of Cellular and Molecular Medicine|May 30, 2020
Expression, function and clinical application of stanniocalcin-1 in cancerFangyu Zhao, Gang Yang, Mengyu Feng, et al.
Molecular Carcinogenesis|July 5, 2022
HIF-1α-regulated stanniocalcin-1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathwayFangyu Zhao, Gang Yang, Jiangdong Qiu, et al.
Cancer Letters|October 1, 2023
Novel strategies optimize immunotherapy by improving the cytotoxic function of T cells for pancreatic cancer treatmentWenhao Luo, Jun Wang, Hao Chen, et al.
Cancer Cell International|March 12, 2020
Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theoryWenhao Luo, Gang Yang, Wentao Luo, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 11, 2023
Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancerGuangyu Chen, Yueze Liu, Dan Su, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 30, 2020
CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinomaGang Yang, Yicheng Wang, Jianchun Xiao, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Cancer Letters|August 9, 2025
Organoids in the research of pancreatic neoplasms: cultivation, applications, and limitationsChangwei Du, Yueze Liu, Xiaoyue Lu, et al.
Biomarker Research|January 25, 2024
Ribosome profiling: a powerful tool in oncological researchDan Su, Chen Ding, Jiangdong Qiu, et al.
Free Radical Biology & Medicine|May 19, 2024
E3 ubiquitin ligase RBCK1 confers ferroptosis resistance in pancreatic cancer by facilitating MFN2 degradationDan Su, Chen Ding, Ruobing Wang, et al.
Cancer Management and Research|June 26, 2024
Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Treated Pancreatic CancerJianchun Xiao, Fangyu Zhao, Wenhao Luo, et al.
Journal of Cellular and Molecular Medicine|May 30, 2020
Expression, function and clinical application of stanniocalcin-1 in cancerFangyu Zhao, Gang Yang, Mengyu Feng, et al.
Molecular Carcinogenesis|July 5, 2022
HIF-1α-regulated stanniocalcin-1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathwayFangyu Zhao, Gang Yang, Jiangdong Qiu, et al.
Cancer Letters|October 1, 2023
Novel strategies optimize immunotherapy by improving the cytotoxic function of T cells for pancreatic cancer treatmentWenhao Luo, Jun Wang, Hao Chen, et al.
Cancer Cell International|March 12, 2020
Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theoryWenhao Luo, Gang Yang, Wentao Luo, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 11, 2023
Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancerGuangyu Chen, Yueze Liu, Dan Su, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 30, 2020
CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinomaGang Yang, Yicheng Wang, Jianchun Xiao, et al.
Pageof 5